Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis

导出原文传递

翻译打印收藏纠错

作者： Sasson, S. C. ^[1] ; Zaunders, J. ^[2] ; Nahar, K. ^[3] ; Munier, C. ^[4] ; Read, S. A. ^[5] ; Ahlensteil, G. ^[6] ; Palendira, U. ; Scolyer, R. A. ; Carlino, M. ; Long, G. V. ; Menzies, A. M. ; Kelleher, A. D.

作者单位： Westmead Inst Med Res, Sydney, NSW, Australia ^[1] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW, Australia ^[2] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia ^[3] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia ^[4] Translat Gastroenterol Unit, Oxford, England ^[5] Univ Sydney, Centenary Inst, Sydney, NSW, Australia ^[6]

发布时间 2020-04-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European journal of cancer

2019年110卷

S21-S22页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis

European journal of cancer

相似文献

European journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis

European journal of cancer

相似文献

European journal of cancer

相关期刊

检索历史清除